Please use this identifier to cite or link to this item:
http://hdl.handle.net/20.500.12188/7322
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Crvenova S | en_US |
dc.contributor.author | Popova, Maja | en_US |
dc.date.accessioned | 2020-03-17T18:52:52Z | - |
dc.date.available | 2020-03-17T18:52:52Z | - |
dc.date.issued | 2020-01-13 | - |
dc.identifier.uri | http://hdl.handle.net/20.500.12188/7322 | - |
dc.description.abstract | Purpose: The aim of this study is to show alectinib efficacy and safety, with focus on alectinib intracranial efficacy. Case presentation: We report on a 46-year-old woman diagnosed as non small cell lung cancer harboring echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion gene. She has intracranial metastases and poor performance status of 3. We treated this patients with alectinib after whole brain irradiation and discontinuation of chemotherapy after two 2 cycles due to progressive brain and liver metastases. Good response was obtained with improving of her performance status without adverse events. Conclusions: We recommend alectinib as a treatment approach for ALK+ NSCLC patients, especially those with CNS metastases at the time of the diagnosis and poor PS. | en_US |
dc.language.iso | en | en_US |
dc.publisher | international journal of medical and biomedical studies | en_US |
dc.relation.ispartof | international journal of medical and biomedical studies | en_US |
dc.subject | CNS metastasis, ALK+ NSCLC patients, alectinib | en_US |
dc.title | CONTEMPORARY TREATMENT OF ALK POSITIVE NON SMALL CELL LUNG CANCER PATIENT WITH BRAIN METASTASES: OUR EXPERIENCE | en_US |
dc.type | Article | en_US |
item.grantfulltext | open | - |
item.fulltext | With Fulltext | - |
crisitem.author.dept | Faculty of Medicine | - |
crisitem.author.dept | Faculty of Medicine | - |
Appears in Collections: | Faculty of Medicine: Journal Articles |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
835-Article Text-1244-1-10-20200131.pdf | CONTEMPORARY TREATMENT OF ALK POSITIVE NON SMALL CELL LUNG CANCER PATIENT WITH BRAIN METASTASES: OUR EXPERIENCE | 1.02 MB | Adobe PDF | View/Open |
Page view(s)
111
checked on Apr 18, 2024
Download(s)
33
checked on Apr 18, 2024
Google ScholarTM
Check
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.